Skip to main content
Top
Published in: Malaria Journal 2/2010

Open Access 01-12-2010 | Oral presentation

Investigating transcriptional regulation of Plasmodium falciparum upon drug perturbation

Authors: Tharina van Brummlen, John VW Becker, Dalu T Mancama, Heinrich Hoppe

Published in: Malaria Journal | Special Issue 2/2010

Login to get access

Excerpt

Gene regulation of the malaria parasite Plasmodium falciparum has proven to be complex with evidence supporting both transcriptional [1, 2] and post-transcriptional level control [3, 4]. Transcriptional profiling of environmentally perturbed malaria parasites can reveal functionally related genes with common regulatory mechanisms that are responsive to external stimuli [2]. By interrogating microarray data derived from P. falciparum populations treated with several drug classes, a subset of four genes potentially involved with the parasite's survival mechanisms following drug perturbation were identified, i.e. general stress response genes. In addition, data from two independent functional genomics investigations on the response of P. falciparum parasites to polyamine biosynthesis inhibitors (DFMO/MDL73811 co-inhibition [5] and cyclohexylamine [6]), revealed four genes of which the transcript abundance appear to be uniquely affected upon polyamine depletion only [5, 6], i.e. perturbation-specific stress response genes. The regulation of this generalized versus perturbation-specific transcriptional responses was subsequently investigated. …
Literature
1.
go back to reference De Silva E, Gehrke A, Olszewski K, León I, Chahal J, Bulyk M, Llinás M: Specific DNA-binding by Apicomplexan AP2 transcription factors. Proc Natl Acad Sci USA. 2008, 105: 8393-8. 10.1073/pnas.0801993105.PubMedCentralCrossRefPubMed De Silva E, Gehrke A, Olszewski K, León I, Chahal J, Bulyk M, Llinás M: Specific DNA-binding by Apicomplexan AP2 transcription factors. Proc Natl Acad Sci USA. 2008, 105: 8393-8. 10.1073/pnas.0801993105.PubMedCentralCrossRefPubMed
2.
go back to reference Hu G, Cabrera A, Kono M, Mok S, Chaal B, Haase S, Engelberg K, Cheemadan S, Spielmann T, Preiser P: Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum. Nat Biotechnol. 2010, 28: 91-8. 10.1038/nbt.1597.CrossRefPubMed Hu G, Cabrera A, Kono M, Mok S, Chaal B, Haase S, Engelberg K, Cheemadan S, Spielmann T, Preiser P: Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum. Nat Biotechnol. 2010, 28: 91-8. 10.1038/nbt.1597.CrossRefPubMed
3.
go back to reference Mair G, Braks J, Garver L, Dimopoulos G, Hall N, Wiegant J, Dirks R, Khan S, Janse C, Waters A: Translational repression is essential for Plasmodium sexual development and mediated by DDX6-type RNA helicase. Science. 2006, 313: 667-9. 10.1126/science.1125129.PubMedCentralCrossRefPubMed Mair G, Braks J, Garver L, Dimopoulos G, Hall N, Wiegant J, Dirks R, Khan S, Janse C, Waters A: Translational repression is essential for Plasmodium sexual development and mediated by DDX6-type RNA helicase. Science. 2006, 313: 667-9. 10.1126/science.1125129.PubMedCentralCrossRefPubMed
4.
go back to reference Shock J, Fischer K, DeRisi J: Whole-genome analysis of mRNA decay in Plasmodium falciparum reveals a global lengthening of mRNA half-life during the intra-erythrocytic development cycle. Genome Biol. 2007, 8: R134-10.1186/gb-2007-8-7-r134.PubMedCentralCrossRefPubMed Shock J, Fischer K, DeRisi J: Whole-genome analysis of mRNA decay in Plasmodium falciparum reveals a global lengthening of mRNA half-life during the intra-erythrocytic development cycle. Genome Biol. 2007, 8: R134-10.1186/gb-2007-8-7-r134.PubMedCentralCrossRefPubMed
5.
go back to reference van Brummelen AC, Olszewski KL, Wilinski D, Llinas M, Louw AI, Birkholtz L-M: Co-inhibition of Plasmodium falciparum S-adenosylmethionine decarboxylase/ornithine decarboxylase reveals perturbation-specific compensatory mechanisms by transcriptome, proteome, and metabolome analyses. J Biol Chem. 2009, 284: 4635-46. 10.1074/jbc.M807085200.PubMedCentralCrossRefPubMed van Brummelen AC, Olszewski KL, Wilinski D, Llinas M, Louw AI, Birkholtz L-M: Co-inhibition of Plasmodium falciparum S-adenosylmethionine decarboxylase/ornithine decarboxylase reveals perturbation-specific compensatory mechanisms by transcriptome, proteome, and metabolome analyses. J Biol Chem. 2009, 284: 4635-46. 10.1074/jbc.M807085200.PubMedCentralCrossRefPubMed
6.
go back to reference Becker J, Mtwisha L, Crampton B, Stoychev S, Van Brummelen A, Reeksting S, Louw A, Birkholtz L-M, Mancama D: Plasmodium falciparum spermidine synthase inhibition results in unique perturbation-specific effects observed on transcript, protein and metabolite levels. BMC Genomics. 2010, 11: 235-10.1186/1471-2164-11-235.PubMedCentralCrossRefPubMed Becker J, Mtwisha L, Crampton B, Stoychev S, Van Brummelen A, Reeksting S, Louw A, Birkholtz L-M, Mancama D: Plasmodium falciparum spermidine synthase inhibition results in unique perturbation-specific effects observed on transcript, protein and metabolite levels. BMC Genomics. 2010, 11: 235-10.1186/1471-2164-11-235.PubMedCentralCrossRefPubMed
7.
go back to reference Van Brummelen AC, Becker JVW: Establishing malaria parasite transfection technology in South Africa. In 22nd South African Society for Biochemistry and Molecular Biology Congress. 2010, South Africa: Bloemfontein, South Africa Van Brummelen AC, Becker JVW: Establishing malaria parasite transfection technology in South Africa. In 22nd South African Society for Biochemistry and Molecular Biology Congress. 2010, South Africa: Bloemfontein, South Africa
Metadata
Title
Investigating transcriptional regulation of Plasmodium falciparum upon drug perturbation
Authors
Tharina van Brummlen
John VW Becker
Dalu T Mancama
Heinrich Hoppe
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Malaria Journal / Issue Special Issue 2/2010
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-9-S2-O32

Other articles of this Special Issue 2/2010

Malaria Journal 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.